Philips Health Technology Ventures, Vesalius Biocapital III and Health Innovations also participated in the round. The funding will enable DEARhealth to scale its operations into more hospitals across the U.S. and to expand internationally with the opening of a new European headquarters in Amsterdam.
The DEARhealth platform uses AI to predict the most effective care pathways for patients with inflammatory bowel disease, chronic pain, liver and kidney diseases and ovarian cancer, with epilepsy and several more chronic conditions expected to be added to the platform soon. These pathways are designed to provide the lowest risk to patients, and can be adjusted by physicians based on changes in condition or unexpected test results.
More articles about AI:
IBM Watson Health VP Lisa Rometty steps down: 3 notes
Dell, Microsoft throw millions behind AI startups to ‘get a window on innovation’
Texas hospital uses AI for stroke care: 3 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
